Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

MULTIANALYTE DIGITAL SENSING WITH QR-CODE MICRONEEDLES FOR MINIMALLY INVASIVE EARLY DIAGNOSIS OF ALZHEIMER

Project description

How QR-coded microneedles could detect Alzheimer’s early

By the time Alzheimer’s symptoms appear, the disease has often been progressing for decades, placing an immense burden on families and healthcare systems. The EIC-funded ALERT project aims to diagnose sooner. Specifically, it will develop microneedle patches that scan for disease markers in real time. The smart needles are QR-coded and can measure multiple disease biomarkers directly from the plasma just beneath the skin. There is no need for complex calibration since the needles translate biomarker levels into a digital code that switches on or off when specific clinical thresholds are met. While the project’s immediate focus is the early detection of Alzheimer’s, it offers a scalable blueprint for tracking everything from sepsis to cancer.

Objective

"ALERT introduces a groundbreaking leap in medical diagnostics, redefining in-vivo sensing with a pioneering digital approach. This revolutionary technology centers on multianalyte digital sensing via QR-coded microneedles—engineered for minimally invasive, highly accurate, and real-time measurement of critical disease biomarkers directly from plasma beneath the skin.

Seamlessly integrating digital innovation with advanced biomedical sensing, ALERT’s microneedles encode biomarker data into a scannable digital QR code, enabling instant and precise diagnostics. These microneedles operate through a unique binary fluorescence mechanism, switching distinctly ""on"" or ""off"" when biomarker concentrations cross predefined clinical thresholds. This digital paradigm eradicates the need for external calibration—a key limitation of traditional analog chemical sensors—ensuring enhanced accuracy, reliability, and ease of use in real-world applications.

With a main focus on early detection of Alzheimer’s Disease (AD), ALERT tackles a pressing global health challenge, particularly urgent given the rapidly aging population. AD often remains clinically undetected for 15 to 20 years, making early diagnosis crucial for improving patient outcomes and reducing the immense social and economic burdens of late-stage management. ALERT's approach includes rigorous validation in animal models, well-defined Key Performance Indicators, advanced material synthesis, cutting-edge device fabrication, and proactive risk mitigation strategies.

Beyond revolutionizing AD diagnostics, ALERT’s digital QR-code microneedle platform holds vast potential for broader medical applications, including early detection of cancer, sepsis, and infectious diseases. Its adaptability extends even further, with applications in environmental monitoring, precision agriculture, and food safety."

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-PATHFINDEROPEN

See all projects funded under this call

Coordinator

UNIVERSITA DI PISA
Net EU contribution
€ 873 080,00
Address
LUNGARNO PACINOTTI 43/44
56126 Pisa
Italy
Region
Centro (IT) Toscana Pisa
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 873 080,00

Participants (4)